Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI007333-03
Application #
3531236
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Project Start
1988-09-01
Project End
1993-08-31
Budget Start
1990-09-01
Budget End
1991-08-31
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost

  Institution

Name
University of Pittsburgh
Department
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213

  Publications

Cillo, Anthony R; Hilldorfer, Benedict B; Lalama, Christina M et al. (2015) Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery. AIDS 29:2121-9
Vadnerkar, Aniket; Toyoda, Yoshiya; Crespo, Maria et al. (2011) Age-specific complications among lung transplant recipients 60 years and older. J Heart Lung Transplant 30:273-81
Vadnerkar, Aniket; Clancy, Cornelius J; Celik, Umit et al. (2010) Impact of mold infections in explanted lungs on outcomes of lung transplantation. Transplantation 89:253-60
Endimiani, Andrea; Doi, Yohei; Bethel, Christopher R et al. (2010) Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2. Biochemistry 49:1014-23
Doi, Y; Paterson, D L; Egea, P et al. (2010) Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin Microbiol Infect 16:33-8
Vadnerkar, Aniket; Nguyen, M Hong; Mitsani, Dimitra et al. (2010) Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients. J Heart Lung Transplant 29:1240-4
Sidjabat, Hanna E; Paterson, David L; Qureshi, Zubair A et al. (2009) Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli. Clin Infect Dis 48:739-44
Doi, Yohei; Husain, Shahid; Potoski, Brian A et al. (2009) Extensively drug-resistant Acinetobacter baumannii. Emerg Infect Dis 15:980-2
McKinnon, John E; Mellors, John W; Swindells, Susan (2009) Simplification strategies to reduce antiretroviral drug exposure: progress and prospects. Antivir Ther 14:1-12
Wilkin, Timothy J; McKinnon, John E; DiRienzo, A Gregory et al. (2009) Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes. J Infect Dis 199:866-71

Showing the most recent 10 out of 32 publications